| GO- Biological Process Pathways |
|
|
|
| Pathway ID |
Pathway Description |
Gene Count |
FDR |
Genes |
| GO.0043922 |
Negative regulation by host of viral transcription |
3 |
0.043 |
Ccl3, Ccl4, Jun |
| GO.0002376 |
Immune system process |
14 |
0.047 |
Ccl3, Ccl4, Clnk, Fasl, Ifng, Irf7, Jun, Junb, Kit, Mylpf, Osm, Rhd, Tbx21, Tnk1 |
| GO.0002763 |
Positive regulation of myeloid leukocyte differentiation |
4 |
0.047 |
Ccl3, Fos, Ifng, Jun |
| GO.0006955 |
Immune response |
10 |
0.047 |
Ccl3, Ccl4, Clnk, Fasl, Ifng, Irf7, Kit, Mylpf, Osm, Tnk1 |
| GO.0050900 |
Leukocyte migration |
5 |
0.047 |
Ccl3, Ccl4, Ifng, Kit, Tbx21 |
| GO.0002891 |
Positive regulation of immunoglobulin mediated immune response |
3 |
0.048 |
Fcer2a, Ifng, Tbx21 |
| GO.0006925 |
Inflammatory cell apoptotic process |
2 |
0.048 |
Fasl, Ifng |
| GO.0009314 |
Response to radiation |
7 |
0.048 |
Cirbp, Dtl, Dusp1, Fos, Jun, Junb, Plk3 |
| GO.0030595 |
Leukocyte chemotaxis |
4 |
0.048 |
Ccl3, Ccl4, Ifng, Kit |
| GO.0032496 |
Response to lipopolysaccharide |
6 |
0.048 |
Ccl3, Fasl, Fos, Ifng, Jun, Junb |
| GO.0034097 |
Response to cytokine |
8 |
0.048 |
Darc, Fos, Ifng, Jun, Junb, Kit, Osm, Socs2 |
| GO.0042493 |
Response to drug |
7 |
0.048 |
Ccl3, Ccl4, Fos, Ifng, Jun, Junb, Prnp |
| GO.0045672 |
Positive regulation of osteoclast differentiation |
3 |
0.048 |
Ccl3, Fos, Ifng |
| GO.0051591 |
Response to cAMP |
4 |
0.048 |
Dusp1, Fos, Jun, Junb |
| GO.0070887 |
Cellular response to chemical stimulus |
14 |
0.048 |
Ccl3, Darc, Dusp1, Ifng, Jun, Junb, Kit, Osm, Plk3, Ppp1r15a, Prnp, Slc16a1, Socs2, Tbx21 |
| GO.1990441 |
Negative regulation of transcription from RNA polymerase II promoter in response to ER stress |
2 |
0.048 |
Jun, Ppp1r15a |
| KEGG Pathways |
|
|
|
| Pathway ID |
Pathway Description |
Gene Count |
FDR |
Genes |
| 5132 |
Salmonella infection |
6 |
2.00E-05 |
Ccl3, Ccl4, Fos, Ifng, Jun, Tjp1 |
| 4060 |
Cytokine-cytokine receptor interaction |
7 |
0.001 |
Ccl3, Ccl4, Fasl, Ifng, Kit, Osm, Tnfrsf9 |
| 4620 |
Toll-like receptor signaling pathway |
5 |
0.001 |
Ccl3, Ccl4, Fos, Irf7, Jun |
| 5142 |
Chagas disease (American trypanosomiasis) |
5 |
0.001 |
Ccl3, Fasl, Fos, Ifng, Jun |
| 5323 |
Rheumatoid arthritis |
4 |
0.004 |
Ccl3, Fos, Ifng, Jun |
| 5168 |
Herpes simplex infection |
5 |
0.009 |
Fasl, Fos, Ifng, Irf7, Jun |
| 5144 |
Malaria |
3 |
0.01 |
Darc, Gypa, Ifng |
| 4380 |
Osteoclast differentiation |
4 |
0.012 |
Fos, Ifng, Jun, Junb |
| 5321 |
Inflammatory bowel disease (IBD) |
3 |
0.017 |
Ifng, Jun, Tbx21 |
| 5161 |
Hepatitis B |
4 |
0.018 |
Fasl, Fos, Irf7, Jun |
| 5140 |
Leishmaniasis |
3 |
0.019 |
Fos, Ifng, Jun |
| 5164 |
Influenza A |
4 |
0.028 |
Fasl, Ifng, Irf7, Jun |
